Advanced Medical Solutions Group (LON:AMS) Share Price Passes Below Two Hundred Day Moving Average – Here’s What Happened
by Renee Jackson · The Cerbat GemAdvanced Medical Solutions Group plc (LON:AMS – Get Free Report) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 216.47 and traded as low as GBX 215. Advanced Medical Solutions Group shares last traded at GBX 218, with a volume of 940,668 shares changing hands.
Wall Street Analyst Weigh In
A number of research firms have commented on AMS. Berenberg Bank reaffirmed a “buy” rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a research report on Tuesday, May 19th. Royal Bank Of Canada restated a “sector perform” rating and issued a GBX 260 price objective on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of GBX 270.25.
Read Our Latest Stock Analysis on AMS
Advanced Medical Solutions Group Trading Down 0.5%
The stock’s fifty day moving average price is GBX 222.55 and its 200 day moving average price is GBX 216.55. The stock has a market cap of £475.04 million, a P/E ratio of 48.45, a PEG ratio of 5.00 and a beta of 0.72. The company has a current ratio of 2.79, a quick ratio of 4.58 and a debt-to-equity ratio of 31.50.
Advanced Medical Solutions Group (LON:AMS – Get Free Report) last issued its quarterly earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a net margin of 4.35% and a return on equity of 3.87%. Equities research analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current year.
About Advanced Medical Solutions Group
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.